Pregnancy
You must inform your doctor if you think you are (or may be) pregnant. Do not take Tarlodix Plus in the first 12 weeks of pregnancy, and do not take it at all after week 13, as its use during pregnancy may be harmful to the baby. If you become pregnant during treatment with Tarlodix Plus, inform your doctor immediately. If you are planning to become pregnant, consult your doctor, who will advise you to take another medication.
Breastfeeding
You must not take Tarlodix Plus during breastfeeding. Inform your doctor if you are breastfeeding or plan to start breastfeeding before taking Tarlodix Plus.
Consult your doctor or pharmacist before taking any medication.
Fertility
There is insufficient data on the effect on fertility.
Driving and operating machines
This medication may affect your ability to drive or operate machines. If you feel unwell, dizzy, tired, or have a headache after taking this medication, do not drive or operate machines and contact your doctor immediately.
Tarlodix Plus contains sodium
This medication contains less than 1mmol of sodium (23 mg) per capsule; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist.This medication should be administered once a day.Your doctor may modify the dose depending on the effect it has on you.
This medication should be taken at the same time of day, before or after a meal.
Swallow the entire capsule with some liquid.
Do not crush or chew the capsules forcefully.
Do not take this medication with grapefruit juice.
Liver and kidney insufficiency
The doses may be modified in liver and kidney insufficiency.
Older patients
Your doctor will reduce the initial dose and adjust the treatment gradually.
Use in children and adolescents
If you take more Tarlodix Plus than you should
Taking too many capsules may cause your blood pressure to be low or dangerously low. You may feel dizzy or weak, and if the drop in blood pressure is severe enough, you may experience shock. Your skin may feel cold and moist, and you may lose consciousness. Excess fluid may accumulate in the lungs (pulmonary edema) causing breathing difficulties that may develop within 24-48 hours after ingestion. Inform your doctor or go to the nearest hospital emergency department if you take too much Tarlodix Plus. Do not drive to the hospital, have someone take you or call an ambulance. Bring the medication packaging with you to indicate to the doctor what you have taken.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Tarlodix Plus
If you forget to take a capsule, leave that capsule and take the next dose at the usual time. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Tarlodix Plus
Your doctor will indicate for how long you should take this medication. Your condition may recur if you interrupt the treatment with this medication before the indicated time by your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Stop taking Tarlodix Plus and consult a doctor immediately if you notice any of the following serious side effects, you may need urgent medical treatment:
Consult your doctor immediately if you experience:
Other side effects:
Inform your doctor if any of the following symptoms worsen or last more than a few days.
Very common: can affect more than 1 in 10 people
Common: can affect up to 1 in 10 people
Rare: can affect up to 1 in 1,000 people
Very rare: can affect up to 1 in 10,000 people
Frequency not known: the frequency cannot be estimated from available data
Inform your doctor if any of the following symptoms worsen or last more than a few days.
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano:http://www.notificaram.es.By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store below 30°C.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition ofTarlodix Plus
The active principles are: amlodipine, ramipril and hydrochlorothiazide.
Tarlodix Plus 5 mg/5 mg/12.5 mg hard capsules:
One capsule contains 5 mg of amlodipine (6.934 mg as amlodipine besilate), 5 mg of ramipril and 12.5 mg of hydrochlorothiazide.
Tarlodix Plus 5 mg/5 mg/25 mg hard capsules:
One capsule contains 5 mg of amlodipine (6.934 mg as amlodipine besilate), 5 mg of ramipril and 25 mg of hydrochlorothiazide.
Tarlodix Plus 5 mg/10 mg/25 mg hard capsules:
One capsule contains 5 mg of amlodipine (6.934 mg as amlodipine besilate), 10 mg of ramipril and 25 mg of hydrochlorothiazide.
Tarlodix Plus 10 mg/10 mg/25 mg hard capsules:
One capsule contains 10 mg of amlodipine (13.868 mg as amlodipine besilate), 10 mg of ramipril and 25 mg of hydrochlorothiazide.
The other components are:
Capule content:microcrystalline cellulose, anhydrous calcium hydrogen phosphate, pregelatinized maize starch, carboxymethylstarch sodium salt (type A), stearate and sodium fumarate.
Capule coating:red iron oxide (E172), titanium dioxide (E171), gelatin, black iron oxide (E172) (only for 5 mg/5 mg/12.5 mg and 10 mg/10 mg/25 mg doses) and yellow iron oxide (E172) (only for 5 mg/5 mg/25 mg, 5 mg/10 mg/25 mg and 10 mg/10 mg/25 mg doses).
Appearance of the product and contents of the package
Tarlodix Plus5 mg/5 mg/12.5 mg are hard capsules: capsule with opaque pink cap and opaque light grey body.
Tarlodix Plus5 mg/5 mg/25 mg are hard capsules: capsule with opaque pink cap and opaque ivory body.
Tarlodix Plus5 mg/10 mg/25 mg are hard capsules: capsule with opaque dark pink cap and opaque yellow body.
Tarlodix Plus10 mg/10 mg/25 mg are hard capsules: capsule with opaque brown cap and opaque caramel body.
Tarlodix Plus is presented in blisters of 10, 28, 30, 60 or 100 hard capsules in cardboard boxes.
Only some package sizes may be marketed.
Marketing Authorization Holder
Adamed Laboratorios, S.L.U.
c/de las Rosas de Aravaca, 31 - 2nd floor
28023 Madrid
Spain
Responsible for manufacturing
Adamed Pharma S.A.
ul. Marszalka Józefa Pilsudskiego 5
95-200 Pabianice
Poland
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Danish:Ramipril/Amlodipin/Hydrochlorthiazid APC
Spanish:Tarlodix Plus 5 mg/5 mg/12.5 mg hard capsules
Tarlodix Plus 5 mg/5 mg/25 mg hard capsules
Tarlodix Plus 5 mg/10 mg/25 mg hard capsules
Tarlodix Plus 10 mg/10 mg/25 mg hard capsules
Last review date of this leaflet: December 2023
The detailed information of this medicinal product is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.es.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.